PDS Bio is the story this week. From a very strong Top 4 performer with a return of 293%, it hit the stratosphere this week with a gain of 295% total return to settle in second overall at 588%. It literally blew by Moderna and BioNTech. It is not just 206% behind the pacesetter, Novavax.
A positive week, moved these stocks from the depths of just an average overall return of 143% up to 168% for a gain of 25% return.
No comments:
Post a Comment